Calibre What Science Can Do

This website contains promotional content about AstraZeneca Medications. This website is intended for healthcare professionals involved in the Acute Coronary Syndrome care pathway, such as hospital specialists from cardiology and cardiology-related departments, including A&E and elderly care, as well as GPs with a specific interest in cardiology, nurses, pharmacists and payers with budget responsibilities in cardiology.

Brilique (ticagrelor) Prescribing Information
Brilique (ticagrelor) SPC (60mg & 90mg film coated tablets)
Brilique (ticagrelor) SPC (90mg orodispersible tablets)
Report an Adverse Event

Jump to Section...

ACS insights
Calibre Home
ACS insights
ACS Case Studies
Hot topics
Expert opinion
Publication Alerts
- Coming soon
Meeting Calendar
Useful links

Useful links

List of links guiding you to guidelines within the UK, EU and International

Guidelines

National Institute of Health and Care Excellence (NICE)

Acute coronary syndromes in adults
Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease
NICE Pathways - Chest pain overview
NSTEMI Quality Standard 68

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management
Ticagrelor for the treatment of acute coronary syndromes
Ticagrelor for preventing atherothrombotic events after myocardial infarction

European Society of Cardiology (ESC)

Clinical practice guidelines

Scottish Intercollegiate Guidelines Network (SIGN) Guidelines

Acute coronary syndrome
Cardiac rehabilitation

American Heart Association (AHA)

Guideline and statements

American College of Cardiology (ACC)

Guidelines and clinical documents

Thank you for visiting the AstraZeneca Medicines website

This link will take you to a website not owned by AstraZeneca. AstraZeneca provides this link as a service to our site visitors. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites.

Do you wish to continue?

Cancel Continue

Thank you for visiting the AstraZeneca Medicines website

Do you wish to continue?

Cancel Continue

Validating...

Welcome to the Calibre portal

This website is intended for healthcare professionals involved in the Acute Coronary Syndrome care pathway, such as hospital specialists from cardiology and cardiology-related departments, including A&E and elderly care, as well as GPs with a specific interest in cardiology, nurses, pharmacists and payers with budget responsibilities in cardiology.

For an optimal video viewing experience, we recommend you view the videos on a good Wifi connection using a desktop browser, such as Google Chrome. The display quality of videos will be reduced when accessing the videos over a slower or shared network connection.

I am not a Healthcare Professional

Welcome to the AstraZeneca Medicines Site

Sorry, your web browser is not supported

Unfortunately, you are using an unsupported browser. Please use Google Chrome 52.0 or Internet Explorer 11 or later. Apologies for any inconvenience.

GB-6911 - June 2017

Cancel

AstraZeneca Medicines

Additional info

Legal Notice and Terms of Use
Privacy Notice
Cookie Policy
Site Map

Contact AstraZeneca

Contact Us
Report Adverse Event

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca by visiting https://aereporting.astrazeneca.com or by calling 0800 783 0033.